Physician

Babak Marefat, MD

According to 2025 Medicare claims, Babak Marefat, MD (NPI: 1417902297) practices ophthalmology in the Topeka, KS market, with the plurality of this provider's patient population coming from Shawnee, KS. This provider's primary affiliated billing organization is COTTON-O'NEIL CLINIC REVOCABLE TRUST (NPI: 1811944457; TIN: 486341644) and primary practice location at 66606-2700. Marefat is affiliated with the Cotton-O'Neil ACO llc (ACO ID: A2506), participating under the MSSP model.

Marefat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,290 traditional Medicare patients, billed 9,148 HCPCS/CPT codes, and received $360,055 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 6,773 prescription claims across 1,027 beneficiaries totaling $352,001 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 2 records totaling $54. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$283K$565K2015 Medicare payment: $470,985 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $472,746 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $478,991 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $476,073 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $565,238 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $479,851 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $492,953 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $411,955 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $373,811 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $360,055 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,4389,182$470,985
20161,45910,464$472,746
20171,53411,376$478,991
20181,68810,783$476,073
20191,69611,442$565,238
20201,3718,792$479,851
20211,47410,207$492,953
20221,27311,192$411,955
20231,3139,923$373,811
20241,2909,148$360,055

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$329K$659K2015 Drug cost: $436,852 (USD; Tot_Drug_Cst)2016 Drug cost: $433,566 (USD; Tot_Drug_Cst)2017 Drug cost: $487,013 (USD; Tot_Drug_Cst)2018 Drug cost: $499,678 (USD; Tot_Drug_Cst)2019 Drug cost: $658,833 (USD; Tot_Drug_Cst)2020 Drug cost: $590,714 (USD; Tot_Drug_Cst)2021 Drug cost: $504,661 (USD; Tot_Drug_Cst)2022 Drug cost: $486,834 (USD; Tot_Drug_Cst)2023 Drug cost: $433,516 (USD; Tot_Drug_Cst)2024 Drug cost: $352,001 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157234,755$436,852
20167284,604$433,566
20177744,790$487,013
20188235,116$499,678
20199345,992$658,833
20209255,675$590,714
20219275,398$504,661
20229655,604$486,834
20239696,152$433,516
20241,0276,773$352,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system403405$89
92012Established patient problem focused exam of visual system9161,492$53
92083Exam of visual field with extended testing174194$42
92250Photography of the retina528540$25
92133Imaging of optic nerve607675$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine673,420$71,049
Brimonidine TartrateBrimonidine Tartrate1979,309$27,188
CombiganBrimonidine Tartrate/Timolol833,741$26,089
LatanoprostLatanoprost3,086151,077$26,008
LumiganBimatoprost622,477$22,148

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$54Sight Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Babak Marefat, MD?

Tedicare shows public-source Medicare data for Babak Marefat, MD (NPI 1417902297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Babak Marefat, MD have ACO affiliation data?

Babak Marefat, MD is shown with ACO affiliation data for Cotton-O'Neil ACO llc (MSSP, ACO ID A2506).

What billing organization is linked to Babak Marefat, MD?

Babak Marefat, MD is linked to COTTON-O'NEIL CLINIC REVOCABLE TRUST (billing NPI 1811944457) in the available physician profile data.

Does Babak Marefat, MD have Open Payments data?

Babak Marefat, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.